increased parametrial fat pad weight_Cdkn1b<tm1Ako>/Cdkn1b<tm1Ako>

http://metadb.riken.jp/0009300I129S1SvCdkn1btm1AkoCdkn1btm1AkoCdkn1btm1Ako

increased parametrial fat pad weight_Cdkn1b<tm1Ako>/Cdkn1b<tm1Ako>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cyclin-dependent kinase inhibitor 1B
  http://metadb.riken.jp/db/mgi_rdf/MGI:104565

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdkn1b<tm1Ako>/Cdkn1b<tm1Ako>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdkn1b<tm1Ako>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased parametrial fat pad weight
  http://purl.obolibrary.org/obo/MP_0009300

文献

http://purl.org/net/cito/citesAsAuthority

• Afia. Naaz, et.al., Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, 18
  http://rdf.ncbi.nlm.nih.gov/pubmed/15469964